Skip to main content
SpringerLink
Log in

Bee venom allergy immunotherapy

Immediate systemic reactions and anaphylactic shock: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Francisco ARS, et al. Successful pretreatment with omalizumab in anaphylactic shock caused by bee venom immunotherapy. Journal of Allergy and Clinical Immunology 139: AB151 abstr. 483, No. 2, Feb 2017 [abstract] - Spain

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bee venom allergy immunotherapy. Reactions Weekly 1659, 48 (2017). https://doi.org/10.1007/s40278-017-32706-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-32706-5

Search

Navigation